Effect of a Modified 5:2 Intermittent Fasting Diet on Population With Overweight or Obesity in China
1 other identifier
interventional
45
1 country
1
Brief Summary
This study aimed to investigate the effects of the modified 5:2 IF dietary intervention on the Chinese population with overweight or obesity based on a self-controlled clinical trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2023
CompletedFirst Submitted
Initial submission to the registry
July 31, 2024
CompletedFirst Posted
Study publicly available on registry
August 14, 2024
CompletedAugust 14, 2024
August 1, 2024
2 years
July 31, 2024
August 11, 2024
Conditions
Outcome Measures
Primary Outcomes (4)
body measurements
weight, BMI, and waistline
24 weeks after intervention
glycolipid metabolism indicators
fasting plasma glucose (FPG), fasting plasma insulin (FPI), fasting C-peptide (FCP), triglycerides (TG), total cholesterol (TC), low density lipoprotein-cholesterol (LDL-C), high density lipoprotein-cholesterol (HDL-C), and uric acid.
24 weeks after intervention
adipokines
leptin and lipocalin
24 weeks after intervention
inflammatory factors before the modified 5:2 IF diet intervention and after 24 weeks of intervention
high sensitivity C-reactive protein (hsCRP), interleukin 6 (IL-6), and tumor necrosis factor-alpha (TNF-α)
24 weeks after intervention
Secondary Outcomes (1)
Change in metabolic components
24 weeks after intervention
Study Arms (1)
Modified 5:2 IF diet
EXPERIMENTALThe modified 5:2 IF diet involves 2 nonconsecutive fasting days (25%-30% of the total required daily energy intake based on ideal body weight) and 5 days of habitual intake (limited total energy intake according to ideal body weight) per week, as well as a 4-week run-in period and a minimum of 6,000 steps of physical activity per day.
Interventions
The modified 5:2 IF diet involves 2 nonconsecutive fasting days (25%-30% of the total required daily energy intake based on ideal body weight) and 5 days of habitual intake (limited total energy intake according to ideal body weight) per week, as well as a 4-week run-in period and a minimum of 6,000 steps of physical activity per day.
Eligibility Criteria
You may qualify if:
- participants aged 18 to 60 years
- participants with a body mass index (BMI) ≥ 24 kg/m2
- participants engaged in light physical labor and their weight was relatively stable.
You may not qualify if:
- participants taking any medication with an effect on body weight in the three months prior to enrollment;
- participants with liver or kidney dysfunction (liver enzymes ≥ 2 times normal; blood creatinine \> the upper limit of normal);
- participants with a history of cardiovascular disease (e.g., coronary heart disease, stroke);
- participants with malignant tumors;
- women during pregnancy or breastfeeding;
- participants deemed unsuitable by the investigator to participate in this trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xiaoli Wang
Hangzhou, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiaoli Wang
Zhejiang Provincial Tongde Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 31, 2024
First Posted
August 14, 2024
Study Start
January 1, 2022
Primary Completion
December 31, 2023
Study Completion
December 31, 2023
Last Updated
August 14, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share